Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cardiovascular Risk: later-stage trial registry
4 of 6 indexed Cardiovascular Risk trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 4 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Cardiovascular Risk: 6 US clinical trials tracked, 4 recruiting.
Cardiovascular Risk is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Novo Nordisk A/S, running 3 of these trials.
Enrollment posture brief
Registry condition cardiovascular-risk
OPEN 4 | RECR 67% | LATE 2 | EARLY 0 | RANK #2866 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Adenocarcinoma of Lung (67% recruiting · 6 trials)
Cardiovascular Risk lists 4 open slots (67% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cardiovascular Risk on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cardiovascular Risk is recruiting above its size-band peers.
4 of 6 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Cardiovascular Risk research.
Novo Nordisk A/S accounts for 3 of 6 trials (50%). 4 distinct sponsors appear on at least one study for this condition label.
-
Typical Cardiovascular Risk enrolment sits around 6,200 participants.
Median target enrolment is 6,200 among the 6 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.
-
Cardiovascular Risk splits between interventional and observational designs.
4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Novo Nordisk A/S
NCT06118281
Impact of the Corrie Lipids Digital Health Program on Lipid Optimization
Johns Hopkins University
NCT07478887
Dose-Response to Resistance Exercise on Cardiovascular Health
University of Pittsburgh
NCT06619444
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Jaeb Center for Health Research
NCT06837181
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation
Novo Nordisk A/S
NCT05021835
Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
Novo Nordisk A/S
NCT06122961
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Cardiovascular Risk records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cardiovascular Risk trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cardiovascular Risk page
6 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Cardiovascular Risk trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Novo Nordisk A/S sponsors the most Cardiovascular Risk trials on record, review their full trial history before evaluating a specific study. See Novo Nordisk A/S's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cardiovascular Risk condition card totals 6 registered trials; most-linked intervention No treatment given; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.